Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-22 19:32 CEST (UTC+2h)

Truncted AUC, low variability [Design Issues]

posted by jag009 - NJ, 2017-08-17 23:50  - Posting: # 17707
Views: 2,464

Hi Helmut,

» It is an open question what a “long half-life drug” is. An numerous conferences both the FDA and the EMA refused to give a definition. Only the Canadian HPFB formerly stated t½ ≥24 hours.

So far no problems for me w FDA. I've ran 6 - 10 of these with t1/2=24 and up (okay, 3 drugs w mean 24 hrs.)

John

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,418 posts in 3,912 threads, 1,173 registered users;
online 17 (0 registered, 17 guests [including 8 identified bots]).

The greatest shortcoming of the human race is our inability
to understand the exponential function.    Albert Bartlett

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed